Peter W Simpson, MD
Gastroenterology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Simpson’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A71224 · Current
Licensed to practise in California · since 2000 · expires 2027-11-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$80,770
Medicare paid this office $80,770 for 340 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 131 | $30,976 | $236 |
| Return visit (30+ min) | 79 | $10,461 | $116 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,325 | $206 |
| Biopsy of large bowel using a flexible endoscope | 69 | $3,344 | $48 |
| New patient visit (45+ min) | 23 | $3,279 | $143 |
See all 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 131 | $30,976 | $236 |
| Return visit (30+ min) | 79 | $10,461 | $116 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,325 | $206 |
| Biopsy of large bowel using a flexible endoscope | 69 | $3,344 | $48 |
| New patient visit (45+ min) | 23 | $3,279 | $143 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $3,142 | $77 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $2,577 | $198 |
| Long return visit (40+ min) | 16 | $2,464 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,207 | $138 |
| Short return visit (20+ min) | 22 | $1,905 | $76 |
| New patient visit (30+ min) | 17 | $1,475 | $87 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 180 | $747 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 19 | $284 | $15 |
Procedures Medicare counted
| Colonoscopy | 106 | More than 81% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 74 | More than 71% of doctors who do this |
Who their Medicare patients are
340 Original Medicare patients in 2024. Average age 75 · Women 45% · Also on Medicaid 7% · Health risk score 0.97. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 55% · Diabetes 23% · Chronic kidney disease 19% · Cancer 19% · Coronary heart disease 16% · Atrial fibrillation 16% · Depression 13% · Heart failure 9% · Dementia 6% · COPD 5% · Stroke 5%.
The office billed $788,672, Medicare allowed $101,185 and paid $80,770; for 941 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 340 | 941 | 75 | 0.97 | $788,672 | $80,770 |
| 2023 | 298 | 640 | 73 | 0.85 | $671,874 | $74,386 |
| 2022 | 317 | 670 | 74 | 0.86 | $638,291 | $76,502 |
| 2021 | 333 | 757 | 74 | 0.97 | $690,668 | $90,467 |
| 2020 | 263 | 609 | 74 | 1.07 | $539,201 | $63,501 |
| 2019 | 281 | 666 | 74 | 1.09 | $588,177 | $65,751 |
| 2018 | 339 | 856 | 72 | 0.95 | $650,141 | $76,991 |
| 2017 | 305 | 833 | 73 | 1.05 | $578,751 | $71,312 |
| 2016 | 294 | 593 | 73 | 0.96 | $576,414 | $75,471 |
| 2015 | 280 | 511 | 72 | 1.00 | $526,046 | $73,901 |
| 2014 | 245 | 433 | 73 | 0.99 | $442,926 | $64,674 |
| 2013 | 223 | 512 | 72 | 1.05 | $426,618 | $60,714 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 119 | $29,489 | $242 |
| Return visit (30+ min) | 63 | $8,009 | $111 |
| Long return visit (40+ min) | 27 | $4,707 | $157 |
| New patient visit (45+ min) | 25 | $3,648 | $146 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,480 | $205 |
| Biopsy of large bowel using a flexible endoscope | 56 | $3,349 | $60 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,741 | $196 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,098 | $75 |
| Short return visit (20+ min) | 20 | $1,607 | $73 |
| New patient visit (30+ min) | 13 | $1,078 | $83 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 144 | $686 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 16 | $264 | $16 |
2022: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 105 | $24,189 | $228 |
| Return visit (30+ min) | 58 | $8,152 | $118 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 28 | $5,872 | $210 |
| New patient visit (45+ min) | 31 | $4,636 | $150 |
| Biopsy of large bowel using a flexible endoscope | 51 | $4,179 | $82 |
| Long return visit (40+ min) | 20 | $3,614 | $164 |
| Short return visit (20+ min) | 34 | $3,005 | $79 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 38 | $2,877 | $72 |
| New patient visit (30+ min) | 17 | $1,512 | $89 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 160 | $813 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 17 | $255 | $15 |
2021: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 110 | $25,437 | $231 |
| Imaging of digestive tract done from the inside of the digestive tract | 11 | $10,648 | $968 |
| Return visit (30+ min) | 87 | $10,624 | $111 |
| Long return visit (40+ min) | 29 | $5,319 | $166 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $4,654 | $212 |
| Biopsy of large bowel using a flexible endoscope | 42 | $3,648 | $87 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | $3,560 | $70 |
| New patient visit (45+ min) | 22 | $3,507 | $159 |
| Short return visit (20+ min) | 36 | $3,388 | $89 |
| New patient visit (30+ min) | 18 | $1,984 | $110 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 161 | $829 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 18 | $268 | $15 |
2020: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 78 | $18,718 | $240 |
| Return visit (30+ min) | 59 | $6,176 | $87 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 25 | $5,492 | $220 |
| Biopsy of large bowel using a flexible endoscope | 39 | $3,727 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,448 | $188 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,416 | $220 |
| New patient visit (45+ min) | 15 | $2,267 | $151 |
| Long return visit (40+ min) | 13 | $2,001 | $133 |
| Short return visit (20+ min) | 31 | $1,966 | $58 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 30 | $1,930 | $60 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 133 | $721 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 35 | $529 | $15 |
2019: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 53 | $12,602 | $238 |
| Biopsy of large bowel using a flexible endoscope | 91 | $10,260 | $113 |
| Return visit (30+ min) | 77 | $9,299 | $97 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,529 | $216 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 37 | $3,303 | $89 |
| New patient visit (45+ min) | 18 | $2,654 | $147 |
| Long return visit (40+ min) | 17 | $2,227 | $131 |
| Short return visit (20+ min) | 30 | $1,949 | $59 |
| New patient visit (30+ min) | 14 | $1,143 | $82 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 133 | $691 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 40 | $628 | $15 |
2018: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 53 | $12,408 | $234 |
| Biopsy of large bowel using a flexible endoscope | 91 | $10,615 | $117 |
| Return visit (30+ min) | 89 | $10,172 | $90 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 24 | $4,998 | $208 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,357 | $207 |
| New patient visit (45+ min) | 29 | $3,723 | $128 |
| Long return visit (40+ min) | 24 | $3,139 | $126 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $2,706 | $93 |
| New patient visit (30+ min) | 23 | $2,134 | $93 |
| Short return visit (20+ min) | 23 | $1,416 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 86 | $1,098 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 171 | $856 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 38 | $585 | $15 |
2017: 15 services
| Biopsy of large bowel using a flexible endoscope | 86 | $10,763 | $125 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 44 | $10,529 | $234 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 44 | $9,335 | $207 |
| Return visit (30+ min) | 70 | $8,636 | $97 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 16 | $3,398 | $212 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,901 | $181 |
| New patient visit (45+ min) | 16 | $2,310 | $144 |
| Long return visit (40+ min) | 12 | $1,624 | $135 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,624 | $96 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 126 | $1,584 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,296 | $65 |
| Short return visit (20+ min) | 18 | $1,134 | $57 |
| New patient visit (30+ min) | 14 | $1,029 | $74 |
| Injection beneath lining of large bowel using a flexible endoscope | 36 | $904 | $24 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 155 | $665 | $4 |
2016: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 53 | $12,290 | $232 |
| Biopsy of large bowel using a flexible endoscope | 84 | $8,372 | $100 |
| Return visit (30+ min) | 56 | $7,459 | $93 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 27 | $5,546 | $205 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 23 | $4,786 | $208 |
| New patient visit (45+ min) | 26 | $3,862 | $149 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,295 | $173 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 38 | $3,281 | $84 |
| Long return visit (40+ min) | 21 | $2,707 | $129 |
| New patient visit (30+ min) | 24 | $2,108 | $88 |
| Short return visit (20+ min) | 25 | $1,784 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,672 | $64 |
| Injection beneath lining of large bowel using a flexible endoscope | 44 | $1,382 | $31 |
2015: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 63 | $17,589 | $279 |
| Biopsy of large bowel using a flexible endoscope | 80 | $11,052 | $138 |
| Return visit (30+ min) | 57 | $7,285 | $104 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $4,757 | $227 |
| New patient visit (45+ min) | 30 | $4,655 | $155 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,472 | $231 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $2,995 | $91 |
| Short return visit (20+ min) | 34 | $2,305 | $61 |
| New patient visit (30+ min) | 21 | $1,635 | $78 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,007 | $92 |
| Injection beneath lining of large bowel using a flexible endoscope | 37 | $1,002 | $27 |
2014: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $10,620 | $265 |
| Biopsy of large bowel using a flexible endoscope | 67 | $10,430 | $156 |
| Imaging of digestive tract done from the inside of the digestive tract | 11 | $10,080 | $916 |
| Return visit (30+ min) | 46 | $4,492 | $92 |
| New patient visit (45+ min) | 27 | $3,898 | $144 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,963 | $228 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,788 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,683 | $179 |
| New patient visit (30+ min) | 23 | $2,182 | $95 |
| Short return visit (20+ min) | 31 | $1,809 | $55 |
| Long return visit (40+ min) | 12 | $1,600 | $133 |
| Injection beneath lining of large bowel using a flexible endoscope | 28 | $736 | $26 |
2013: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 38 | $9,974 | $262 |
| Biopsy of large bowel using a flexible endoscope | 63 | $7,737 | $123 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,786 | $115 |
| Return visit (30+ min) | 36 | $3,546 | $89 |
| New patient visit (30+ min) | 36 | $3,150 | $88 |
| Short return visit (20+ min) | 41 | $3,059 | $62 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,842 | $189 |
| New patient visit (45+ min) | 18 | $2,617 | $145 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,524 | $117 |
| Injection beneath lining of large bowel using a flexible endoscope | 24 | $635 | $26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $545 | $34 |
Drugs they prescribed that Part D paid
$94,982
Pharmacies billed $94,982 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 463) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
361 generic and 102 brand-name prescriptions · $94,982 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mesalamine | 13 | $6,907 | $531 |
| Sod Sulf-Potass Sulf-Mag Sulf | 81 | $5,286 | $65 |
| Pantoprazole | 52 | $1,466 | $28 |
| Peg 3350-Electrolyte | 54 | $1,170 | $22 |
| Gavilyte-G | 47 | $630 | $13 |
See all 7 drugs
| Mesalamine | 13 | $6,907 | $531 |
| Sod Sulf-Potass Sulf-Mag Sulf | 81 | $5,286 | $65 |
| Pantoprazole | 52 | $1,466 | $28 |
| Peg 3350-Electrolyte | 54 | $1,170 | $22 |
| Gavilyte-G | 47 | $630 | $13 |
| Omeprazole | 45 | $562 | $12 |
| Gavilyte-C | 18 | $273 | $15 |
Year by year
| 2024 | 463 | 269 | 0% (0) | 22% | $94,982 |
| 2023 | 487 | 283 | 0% (0) | 28% | $75,717 |
| 2022 | 468 | 248 | None | 42% | $302,941 |
| 2021 | 471 | 256 | 0% (0) | None | $105,234 |
| 2020 | 390 | 179 | 0% (0) | None | $115,042 |
| 2019 | 423 | 204 | 0% (0) | None | $140,796 |
| 2018 | 381 | 199 | 0% (0) | None | $192,969 |
| 2017 | 383 | 193 | 0% (0) | 45% | $122,258 |
| 2016 | 418 | 180 | None | None | $196,813 |
| 2015 | 438 | 169 | None | None | $116,299 |
| 2014 | 356 | 125 | 0% (0) | 31% | $78,543 |
| 2013 | 338 | 98 | 0% (0) | 30% | $75,976 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Mesalamine | 21 | $13,077 | $623 |
| Sod Sulf-Potass Sulf-Mag Sulf | 90 | $6,993 | $78 |
| Peg 3350-Electrolyte | 111 | $2,644 | $24 |
| Omeprazole | 54 | $1,172 | $22 |
| Pantoprazole | 48 | $1,062 | $22 |
| Sulfasalazine | 11 | $350 | $32 |
2022: 8 drugs
| Mesalamine | 20 | $16,497 | $825 |
| Mesalamine Er | 11 | $12,120 | $1,102 |
| Suprep | 73 | $8,500 | $116 |
| Sod Sulf-Potass Sulf-Mag Sulf | 24 | $1,811 | $75 |
| Colestipol | 15 | $1,763 | $118 |
| Peg 3350-Electrolyte | 78 | $1,415 | $18 |
| Pantoprazole | 37 | $1,050 | $28 |
| Omeprazole | 46 | $971 | $21 |
2021: 13 drugs
| Creon | 12 | $29,335 | $2,445 |
| Suprep | 119 | $13,064 | $110 |
| Mesalamine | 19 | $12,531 | $660 |
| Sucralfate | 21 | $4,552 | $217 |
| Balsalazide Disodium | 12 | $3,828 | $319 |
| Omeprazole | 69 | $1,480 | $21 |
| Mercaptopurine | 11 | $678 | $62 |
| Pantoprazole | 17 | $603 | $35 |
| Famotidine | 16 | $382 | $24 |
| Peg 3350-Electrolyte | 15 | $249 | $17 |
| Gavilyte-G | 18 | $219 | $12 |
| Peg-3350 and Electrolytes | 17 | $177 | $10 |
| Gavilyte-C | 12 | $170 | $14 |
2020: 10 drugs
| Budesonide Ec | 15 | $13,931 | $929 |
| Mesalamine | 12 | $10,314 | $859 |
| Balsalazide Disodium | 14 | $8,496 | $607 |
| Suprep | 57 | $5,983 | $105 |
| Omeprazole | 88 | $1,665 | $19 |
| Sucralfate | 11 | $1,477 | $134 |
| Pantoprazole | 17 | $496 | $29 |
| Peg 3350-Electrolyte | 22 | $331 | $15 |
| Gavilyte-N | 16 | $224 | $14 |
| Gavilyte-C | 16 | $200 | $13 |
2019: 10 drugs
| Suprep | 64 | $6,358 | $99 |
| Balsalazide Disodium | 15 | $5,708 | $381 |
| Omeprazole | 75 | $1,977 | $26 |
| Mercaptopurine | 20 | $1,374 | $69 |
| Pantoprazole | 31 | $840 | $27 |
| Gavilyte-C | 24 | $316 | $13 |
| Gavilyte-N | 17 | $300 | $18 |
| Peg 3350-Electrolyte | 13 | $228 | $18 |
| Ondansetron | 12 | $213 | $18 |
| Peg 3350-Electrolyte | 17 | $157 | $9 |
2018: 9 drugs
| Lialda | 13 | $14,638 | $1,126 |
| Mesalamine | 14 | $13,905 | $993 |
| Suprep | 71 | $6,687 | $94 |
| Mercaptopurine | 16 | $1,372 | $86 |
| Omeprazole | 60 | $1,012 | $17 |
| Peg 3350-Electrolyte | 40 | $658 | $16 |
| Pantoprazole | 27 | $519 | $19 |
| Gavilyte-N | 26 | $442 | $17 |
| Polyethylene Glycol 3350 | 14 | $406 | $29 |
2017: 11 drugs
| Humira | 12 | $53,268 | $4,439 |
| Lialda | 20 | $24,616 | $1,231 |
| Mesalamine | 11 | $7,317 | $665 |
| Suprep | 52 | $4,599 | $88 |
| Mercaptopurine | 19 | $1,757 | $92 |
| Omeprazole | 54 | $762 | $14 |
| Peg 3350-Electrolyte | 56 | $758 | $14 |
| Pantoprazole | 27 | $748 | $28 |
| Gavilyte-N | 27 | $432 | $16 |
| Polyethylene Glycol 3350 | 11 | $422 | $38 |
| Sucralfate | 14 | $287 | $20 |
2016: 12 drugs
| Humira | 13 | $51,222 | $3,940 |
| Lialda | 24 | $37,567 | $1,565 |
| Ursodiol | 11 | $4,507 | $410 |
| Dexilant | 17 | $4,454 | $262 |
| Mercaptopurine | 25 | $1,391 | $56 |
| Peg 3350-Electrolyte | 73 | $1,111 | $15 |
| Omeprazole | 80 | $1,001 | $13 |
| Gavilyte-N | 33 | $587 | $18 |
| Polyethylene Glycol 3350 | 13 | $465 | $36 |
| Pantoprazole | 13 | $313 | $24 |
| Ondansetron Odt | 13 | $286 | $22 |
| Dicyclomine | 14 | $97 | $7 |
2015: 13 drugs
| Humira | 12 | $38,360 | $3,197 |
| Lialda | 23 | $18,532 | $806 |
| Budesonide Ec | 13 | $9,981 | $768 |
| Ursodiol | 14 | $8,495 | $607 |
| Mercaptopurine | 28 | $1,930 | $69 |
| Omeprazole | 87 | $1,261 | $14 |
| Peg 3350-Electrolyte | 59 | $989 | $17 |
| Diphenoxylate-Atropine | 12 | $746 | $62 |
| Polyethylene Glycol 3350 | 15 | $592 | $39 |
| Gavilyte-N | 19 | $351 | $18 |
| Pantoprazole | 12 | $274 | $23 |
| Ondansetron Odt | 16 | $272 | $17 |
| Ciprofloxacin | 16 | $221 | $14 |
2014: 9 drugs
| Humira | 12 | $31,494 | $2,624 |
| Moviprep | 31 | $2,415 | $78 |
| Mercaptopurine | 26 | $1,774 | $68 |
| Omeprazole | 81 | $979 | $12 |
| Peg-3350 | 32 | $548 | $17 |
| Polyethylene Glycol 3350 | 14 | $508 | $36 |
| Azathioprine | 12 | $301 | $25 |
| Pantoprazole | 24 | $288 | $12 |
| Allopurinol | 11 | $47 | $4 |
2013: 9 drugs
| Humira | 13 | $30,266 | $2,328 |
| Lialda | 13 | $5,047 | $388 |
| Dexilant | 12 | $1,899 | $158 |
| Mercaptopurine | 29 | $1,732 | $60 |
| Moviprep | 23 | $1,680 | $73 |
| Omeprazole | 75 | $1,409 | $19 |
| Polyethylene Glycol 3350 | 23 | $672 | $29 |
| Pantoprazole | 27 | $322 | $12 |
| Metronidazole | 15 | $311 | $21 |
Money from drug and device companies
$33 in 2025
| 2025 | 2 | 2 | None | $33 |
| 2024 | 1 | 1 | None | $12 |
| 2023 | 1 | 1 | None | $13 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Micro-tech Endoscopy USA | Lockado | $19 | 1 payment
|
| Conmed | Conmed Biliary | $14 | 1 payment
|
See all 2 published payments
| Micro-tech Endoscopy USA | Meals · 2025-10-04 | Lockado | $19 |
| Conmed | Meals · 2025-10-04 | Conmed Biliary | $14 |
See earlier years (2024, 2023)
2024: $12
| Micro-tech Endoscopy USA | Eyemx | $12 | 1 payment
|
2023: $13
| Celgene | Zeposia | $13 | 1 payment
|
Professional record
- NPI
- 1043499478
- Licence
- CA A71224California A71224: Current · expires 2027-11-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-11-02
- NPI last updated
- 2012-01-13
This is when the NPI record was last certified, not a medical board exam.